tanzania times : Latest News and In-depth Analysis
Contact Us
Search

Sports

tanzania times : Latest News and In-depth Analysis
HomeSports
Sports

Mar 5, 2025

Yuwell Medical Joins CFA Team China as Official Partner: Elevating Health Celebrating Sport

BEIJING,March 3,2025-- On March 2,Yuwell Medical and the CFA Team China announced an official partnership at a signing ceremony in Beijing under the theme "Elevating Health Celebrating Sport.&quo

All News

Sports

LG INTRODUCES INNOVATIVE TOTAL HOME SOLUTIONS AT KBIS AND IBS 2025

Company Presents Expanded Range of Solutions for Home Design and Residential Builder Markets at Major Industry Tradeshows in Las Vegas

Feb 26, 2025

Sports

ADA and IPification Partner to Revolutionize Seamless Authentication for Digital Apps

SINGAPORE,Feb. 25,2025-- ADA,a leader in data and AI-driven digital transformation and all-in-one authentication solutions,and IPification,a pioneer in seamless mobile authentication,have announced t

Feb 26, 2025

Sports

Medtronic Malaysia and Malaysian Society of Colorectal Surgeons sign MOU to enhance medical training and education programs

KUALA LUMPUR,Malaysia,Feb. 25,2025-- Medtronic plc,a global leader in healthcare technology,announcedthat Medtronic Malaysia and Malaysian Society of Colorectal Surgeons (MSCRS) have signed a Memorand

Feb 26, 2025

Sports

"The Future of Travel": Trip.com Group to Showcase Next-Gen Tech at ITB Berlin 2025

Trip.com Group to launch joint Technology Game Changers: Future Trends in Travel & Tourism report at ITB Berlin Press Conference

Feb 26, 2025

Lessons from Japan's AMR Response for the Global Community

https://iris.who.int/handle/10665/380481 TOKYO,Feb. 25,2025-- World Health Organization (WHO) Regional Office for the Western Pacific (WPRO) has released Japan\'s AMR Response 2013–2025 alongside Tok

Feb 26, 2025

BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED)

SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the

Feb 26, 2025

1 ... 17 18 19 20 21 22 23 ... 70